Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain

This study has been completed.
Information provided by:
Advocate Hospital System Identifier:
First received: April 30, 2008
Last updated: January 13, 2011
Last verified: June 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)